Which laboratory test should be ordered to detect the Factor V Leiden mutation?

Laboratory Testing for Factor V Leiden

Order a direct DNA-based molecular genetic test for the Factor V Leiden (R506Q) mutation, which is the definitive and preferred diagnostic method. 1

Primary Testing Approach

The most recent ACMG guidelines (2025) establish that molecular genetic testing via DNA analysis is the gold standard for detecting Factor V Leiden 1. This approach offers several critical advantages:

• Highest specificity and sensitivity with extremely low false-positive and false-negative rates
• Not affected by anticoagulation therapy (heparin, warfarin) or other coagulation abnormalities
• Distinguishes heterozygotes from homozygotes, which is essential for risk stratification
• Can be performed at any time, regardless of acute thrombotic events or medications

Available Testing Methods

Multiple validated DNA-based techniques are acceptable 2:

• PCR-based methods (most common):
  • Allele-specific PCR
  • Real-time quantitative PCR (qPCR) with allele discrimination 3
  • Restriction endonuclease digestion of PCR amplicons (AMP-FLPs)
• Allele-specific oligonucleotide probe hybridization
• Other validated automated platforms

All methods must adhere to ACMG/CAP quality assurance guidelines 2.

Alternative: Functional APC Resistance Testing

While functional coagulation assays for activated protein C (APC) resistance exist, they are NOT recommended as standalone tests 2. Here's why:

Limitations of Functional Tests:

• High sensitivity but suboptimal specificity for Factor V Leiden 2
• Cannot distinguish heterozygotes from homozygotes (critical for management decisions)
• Interfered with by:
  • Heparin therapy
  • Lupus anticoagulant 2, 4
  • Oral contraceptives
  • Pregnancy
  • Factor V, X, or II deficiencies 4

When Functional Tests Might Be Used:

If a functional APC resistance assay is performed and returns positive, DNA testing must follow for confirmation and genotype determination 2. The modified functional assays using diluted plasma or specific snake venoms (Russell Viper Venom Time-based or Crotalus viridis helleri venom-based) show improved specificity 5, 4, 6, but DNA confirmation remains necessary.

Clinical Testing Algorithm

For symptomatic patients or those meeting testing criteria:

1. Order: Factor V Leiden genetic test (DNA-based)
2. Specify: Molecular analysis for R506Q mutation
3. Consider concurrent testing for: Prothrombin G20210A mutation (can be multiplexed with Factor V Leiden) 2

For patients on anticoagulation or with lupus anticoagulant:

• Proceed directly to DNA testing (skip functional assays entirely) 2

For family members of known Factor V Leiden carriers:

• DNA testing is specifically recommended 2

Important Caveats

• Factor V Leiden (R506Q) is the ONLY Factor V mutation routinely tested in clinical practice 2. Other rare variants (Factor V Cambridge, Factor V Hong Kong) are not clinically indicated 2.

• Do not order "APC resistance" alone as a definitive test—it requires DNA confirmation and doesn't provide genotype information needed for management decisions.

• The test result should explicitly state whether the patient is heterozygous or homozygous, as this dramatically affects thrombotic risk (heterozygotes: ~7-fold increased VTE risk; homozygotes: ~80-fold increased risk) 2.